SM-1 Combined With Temozolomide in Subjects With Refractory or Recurrent High-Grade Gliomas
Clinical trial NCT07635173 · COMPLETED
Trial details
- NCT number
- NCT07635173
- Sponsor
- Shenzhen Zhenxing Medical Technology Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-19
- Primary completion
- 2024-04-22
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.